XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Long-Term Debt
9 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Long-Term Debt

7. Long-term Debt

Long-term debt consists of the following:

 

 

 

June 30,
2022

 

 

September 30,
2021

 

Series B term loan

 

$

1,187.9

 

 

$

1,001.7

 

Receivables financing agreement

 

 

171.4

 

 

 

150.4

 

Revolving Credit Agreement

 

 

 

 

 

 

Financing costs, net

 

 

(10.9

)

 

 

(11.1

)

Total debt, net

 

 

1,348.4

 

 

 

1,141.0

 

Less: Current portion of long-term debt

 

 

12.0

 

 

 

10.4

 

Long-term debt, net

 

$

1,336.4

 

 

$

1,130.6

 

 

First Lien credit facility term loans and Series B Term Loan due 2029

In connection with the KKR Acquisition, the Company and a group of financial institutions entered into a credit agreement (the “Credit Agreement”) dated December 18, 2013. The Credit Agreement consisted of seven-year $1,460.0 term loans (“First Lien Term Loans”) and a five-year $210.0 revolving credit facility. All amounts outstanding under the Credit Agreement were collateralized by substantially all of the assets of the Company.

On April 22, 2022, the Company, entered into Amendment No. 6 to the Credit Agreement (the “Amendment Agreement”). Under the terms of the Amendment Agreement, the existing Credit Agreement (as amended prior to but not including under the Amendment Agreement, the “Amended Credit Agreement”) was amended to provide for: (i) a $1,200.0 seven-year term loan (the “Series B Term Loan”) and (ii) a $300.0 five-year revolving credit facility (the “Revolving Credit Facility”). The Series B Term Loan matures on April 22, 2029 and bears interest at a rate per annum of a secured overnight funding rate (“Term SOFR”) plus a margin of 3.25% or a base rate (“ABR”) plus a margin of 2.25%, subject to SOFR and ABR floors of 0.50% and 1.50%, respectively. The Company used the net proceeds from the Series B Term Loan to repay all amounts outstanding under the Company’s Amended Credit Agreement. As a result of the repayment of the amounts outstanding under the Company's Amended Credit Agreement, the Company recorded a loss on debt extinguishment of $12.6 due to accelerated amortization of deferred financing fees and original issue discount included in the Other (expense) income line of the Consolidated Statements of Operations. An original issue discount of $12.0 was incurred when the Series B Term Loan was issued and is being amortized using the effective interest method over the life of the debt, resulting in an effective yield of 3.42%. Debt repayments for the Series B Term Loan totaled $1,003.3 and $7.8 for the nine month periods ended June 30, 2022 and 2021.

Revolving credit facility

The Company has a five-year $300.0 revolving credit facility (the “Revolving Credit Facility”) that matures on April 22, 2027 and bears interest at a rate per annum of Term SOFR plus a margin ranging from 2.00% to 2.50% or ABR plus a margin ranging from 1.00 to 1.50%, subject to SOFR and ABR floors of 0.00% and 1.00%, respectively, with the margin on the Revolving Credit Facility determined based on the Company’s first lien net leverage ratio. The Revolving Credit Facility replaced the previous $260.0 revolving credit facility under the Amended Credit Agreement. There were $165.0 borrowings under the facility for the nine months ended June 30, 2022, of which, $165.0 were repaid during the same period. There were no borrowings or repayments under the facility for the nine months ended June 30, 2021.

Receivables financing agreement

On April 28, 2017, the Company, through a wholly-owned subsidiary, entered into a receivables financing agreement (the “Receivables Financing Agreement”). On February 19, 2021, the Company entered into the Second Amendment to the Receivables Financing Agreement (the "Second Amendment") which extended the term through February 20, 2024 and increased the borrowing capacity to $235.0 through September 20, 2021 and $250.0 thereafter. On June 22, 2022, the Company entered into the Third Amendment to the Receivables Financing Agreement (the "Third Amendment") which extended the term through June 22, 2025 and increased the borrowing capacity to $275.0. All amounts outstanding under the Receivables Financing Agreement are collateralized by substantially all of the accounts receivable and unbilled revenue of the Company. During the nine months ended June 30, 2022 the

Company borrowed $224.0 against the capacity and voluntarily repaid $203.0. During the nine months ended June 30, 2021 the Company borrowed $24.5 against the capacity and voluntarily repaid $24.6.

The following are the scheduled maturities of long-term debt for the remainder of fiscal 2022 and the following five fiscal years and thereafter, which do not include any estimated excess cash flow payments:

 

 

 

 

 

2022

 

$

3.0

 

2023

 

 

12.0

 

2024

 

 

12.0

 

2025

 

 

183.4

 

2026 and thereafter

 

 

1,161.0

 

Total long-term debt

 

 

1,371.4

 

Less: Current maturities

 

 

12.0

 

Less: Original issue discount

 

 

12.1

 

Less: Financing costs

 

 

10.9

 

Total long-term debt, net

 

$

1,336.4

 

 

The Company has estimated the fair value of its long-term debt to be approximately $1,311.5 and $1,148.7 as of June 30, 2022 and September 30, 2021, respectively. Fair value is based on market bid prices around period-end (Level 2 inputs).